REFERENCES
- Pin I, Gibson P G, Kolendowicz R, Girgis-Gabardo A, Denburg J, Hargreave F E, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25–29, [INFOTRIEVE], [CSA]
- Green R H, Brightling C E, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw A J, Pavord I D. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715–1721, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pizzichini E, Pizzichini M M, Gibson Parameswaran P, Berman L, Efthimiadis A, Gleich G G, Dolovich J, Hargreave F E. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998; 158: 1511–1517, [INFOTRIEVE], [CSA]
- Brightling C E, Monteiro W, Ward R, Parker D, Morgan M D, Wardlaw A J, Pavord I D. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356 1480–1485, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brightling C E, Monterio W, Green R H, Parker D, Morgan M D, Wardlaw A J, Pavord I D. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95: 999–1002, [INFOTRIEVE], [CSA], [CROSSREF]
- Rytila P H, Lindqvist A E, Laitinen L A. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 1116–1119, [INFOTRIEVE], [CSA], [CROSSREF]
- Sutherland E R, Pak J, Langmack E L, Silkoff P E, Martin R J. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002; 96: 482–486, [INFOTRIEVE], [CSA], [CROSSREF]
- Pizzichini E, Pizzichini M M, Leigh R, Djukanovic R, Sterk P J. Safety of sputum induction. Eur Respir J Suppl 2002; 37: 9s–18s, [INFOTRIEVE], [CSA], [CROSSREF]
- Leigh R, Kamada D H, Pugsley S O, Efthimiadis A, Kitching A D, Hargreave F E. The prevalence of cardiac dysfunction in patients with COPD. Am J Respir Crit Care Med 2001; 163: A908, [CSA]
- Pizzichini E, Leigh R, Pizzichini M M, Hargreave F E. Sputum eosinophilia predicts clinical benefit for inhaled budesonide treatment in patients with COPD. 2003; A320, [CSA]
- Pizzichini M M, Pizzichini E, Clelland L, Efthimiadis A, Mahony J, Dolovich J, Hargreave F E. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med 1997; 155 1501–1508, [INFOTRIEVE], [CSA]
- Pizzichini E, Pizzichini M M, Efthimiadis A, Evans S, Morris M M, Squillace D, Gleich G J, Dolovich J, Hargreave F E. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308–317, [INFOTRIEVE], [CSA]
- Nisar M, Walshaw M, Earis J E, Pearson M G, Calverley P M. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990; 45: 190–194, [PUBMED], [INFOTRIEVE], [CSA]
- Kelly M G, Brown V, Martin S L, Ennis M, Stuart Elborn J. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest 2002; 122: 955–959, [INFOTRIEVE], [CSA], [CROSSREF]
- Wong H H, Fahy J V. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997; 156: 299–303, [INFOTRIEVE], [CSA]
- Vlachos-Mayer H, Leigh R, Sharon R F, Hussak P, Hargreave F E. Success and safety of sputum induction in the clinical setting. Eur Respir J 2000; 16: 997–1000, [INFOTRIEVE], [CSA], [CROSSREF]